You are not currently logged in.
Access your personal account or get JSTOR access through your library or other institution:
Maintaining Reduced Viral Fitness and CD4 Response in HIV-Infected Patients with Viremia Receiving a Boosted Protease Inhibitor
Philip Grant, Jonathan Taylor, Pat Cain, William Short, Joel Gallant, Charles Farthing, Gary Thal, Eoin Coakley and Andrew Zolopa
Clinical Infectious Diseases
Vol. 48, No. 5 (Mar. 1, 2009), pp. 680-682
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/40309284
Page Count: 3
Preview not available
When fully suppressive regimens are not available, incompletely suppressive regimens also provide immunologic benefits. In this study, with stable background therapy, human immunodeficiency virus (HlV)-infected patients who were randomized to receive atazanavir or boosted atazanavir, compared with those who continued boosted protease inhibitor therapy, maintained similar virologic and immunologic control, resistance-mutation patterns, and replication capacities with reduced use of lipid-lowering medication.
Clinical Infectious Diseases © 2009 Oxford University Press